DE68902490T2 - Pharmazeutische zusammensetzung. - Google Patents

Pharmazeutische zusammensetzung.

Info

Publication number
DE68902490T2
DE68902490T2 DE8989300865T DE68902490T DE68902490T2 DE 68902490 T2 DE68902490 T2 DE 68902490T2 DE 8989300865 T DE8989300865 T DE 8989300865T DE 68902490 T DE68902490 T DE 68902490T DE 68902490 T2 DE68902490 T2 DE 68902490T2
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
antagonize
chem
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989300865T
Other languages
English (en)
Other versions
DE68902490D1 (de
Inventor
James Franklin Resch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeneca Inc
Original Assignee
ICI Americas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ICI Americas Inc filed Critical ICI Americas Inc
Application granted granted Critical
Publication of DE68902490D1 publication Critical patent/DE68902490D1/de
Publication of DE68902490T2 publication Critical patent/DE68902490T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE8989300865T 1988-02-09 1989-01-30 Pharmazeutische zusammensetzung. Expired - Fee Related DE68902490T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15386488A 1988-02-09 1988-02-09

Publications (2)

Publication Number Publication Date
DE68902490D1 DE68902490D1 (de) 1992-09-24
DE68902490T2 true DE68902490T2 (de) 1992-12-24

Family

ID=22549061

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989300865T Expired - Fee Related DE68902490T2 (de) 1988-02-09 1989-01-30 Pharmazeutische zusammensetzung.

Country Status (6)

Country Link
EP (1) EP0328282B1 (de)
JP (1) JPH01265076A (de)
AT (1) ATE79540T1 (de)
DE (1) DE68902490T2 (de)
ES (1) ES2051996T3 (de)
GR (1) GR3005444T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795468A (en) * 1987-12-23 1989-01-03 Zimmer, Inc. Mechanism and method for locking a bearing insert to the base of a prosthetic implant
EP1966158B1 (de) 2005-12-20 2012-08-08 AstraZeneca AB Substituierte cinnolinderivate als modulatoren des gabaa-rezeptors und verfahren zu ihrer synthese
US7465795B2 (en) 2005-12-20 2008-12-16 Astrazeneca Ab Compounds and uses thereof
AR067028A1 (es) * 2007-06-19 2009-09-30 Astrazeneca Ab Compuestos y usos de los mismos 849
WO2010123441A1 (en) * 2009-04-21 2010-10-28 Astrazeneca Ab Crystalline form of 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n-propylcinnoline-3- carboxamide hydrogen sulphate, for treatment of anxiety disorders
WO2010123443A1 (en) * 2009-04-21 2010-10-28 Astrazeneca Ab Pharmaceutical composition comprising 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n- propylcinnoline-3-carboxamide hydrogen sulphate.
WO2010123440A1 (en) * 2009-04-21 2010-10-28 Astrazeneca Ab Pharmaceutical composition comprising 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n- propylcinnoline-3-carboxamide hydrogen sulphate and rate-controlling polymer
WO2011021979A1 (en) * 2009-08-18 2011-02-24 Astrazeneca Ab Cinnoline compounds, their preparation, and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8513639D0 (en) * 1985-05-30 1985-07-03 Ici America Inc Cinnoline compounds
WO1988007533A1 (en) * 1987-03-25 1988-10-06 Yoshitomi Pharmaceutical Industries, Ltd. Thienocinnoline compounds and their medicinal application

Also Published As

Publication number Publication date
EP0328282A3 (en) 1990-04-25
ATE79540T1 (de) 1992-09-15
EP0328282B1 (de) 1992-08-19
EP0328282A2 (de) 1989-08-16
GR3005444T3 (de) 1993-05-24
DE68902490D1 (de) 1992-09-24
JPH01265076A (ja) 1989-10-23
ES2051996T3 (es) 1994-07-01

Similar Documents

Publication Publication Date Title
DK287285A (da) Benzodiazepinderivat og farmaceutisk praeparat indeholdende et saadant derivat
DK139588D0 (da) Benzodiazepinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
FI953384A0 (fi) Uusi bentsolitiaditsiiniyhdiste, menetelmä sen valmistamiseksi ja sitä sisältävät farmaseuttiset koostumukset
ATE79540T1 (de) Pharmazeutische zusammensetzung.
SE9003973D0 (sv) Glycerol, ett framstaellningsfoerfarande foer desamma samt terapeutiska kompositioner innehaallande dem
ATE75933T1 (de) Zahnaerztliche haftmittelzusammensetzung.
PT88681A (pt) A process for the preparation of pharmaceutical compositions containing piperidinoalkanol derivatives
DK0541263T3 (da) 5-Piperazinylalkyl-1,5-benzothiazepinoner, der er nyttige som calciumantagonister
ITMI920132A1 (it) Derivati della 8-(1-amminocicloalchil)1, 3-dialchilxantina, procedimenbto di preparazione e loro composizioni farmaceutiche antidepressive, nootropiche e psicostimolanti
ZW6789A1 (en) &-adrenergic receptor antagonists
ATE85056T1 (de) Tetracyclische indolderivate.
DK535388A (da) Anvendelse af piperidinopropiophenonforbindelse til fremstilling af et hypotensivt middel
ZW6889A1 (en) &-adrenergic receptor antagonists
DK656889A (da) Azabicykliske derivater
ES2057121T3 (es) Antagonistas de los receptores alfa-adrenergicos.
DK0462556T3 (da) Hypotriglyceridæmisk anvendelse af bis(3,5-di-alkyl-4-hydroxyphenylthio)methaner
IT1191704B (it) Procedimento per la preparazione di derivati dell'azetidinone

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee